Developing next generation treatments to preserve vision for patients with diseases affecting the back of the eye

Global locations

Corporate HQ

Oxurion nv
Gaston Geenslaan 1
B-3001 Leuven
Belgium

T +32 16 75 13 10
F +32 16 75 13 11

USA

ThromboGenics, Inc. - subsidiary of Oxurion nv
101 Wood Avenue South
Suite 610
Iselin, NJ 08830 USA

T +1 732 590 2900
T +1 855 301 1600

Stay in touch

Fill out the contact form below to receive all information and latest news about Oxurion.

Or follow us on Twitter and LinkedIn.

  

Contact

Contact

Your information

I wish to receive

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Report a safety related event

I wish to report a safety related event (side effect, use during pregnancy or lactation, overdose, treatment errors such as overdose, usage outside the conditions in the label).

I am a patient

I am a healthcare professional